InsidersTradesSigma
Discover the full record of transactions filed by Vignola Mark J., 首席财务官. Director active across 1 company, notably Terns Pharmaceuticals, Inc.. In total, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 31 May 2022. The latest transaction was filed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Mark J. Vignola is the Chief Financial Officer at Terns Pharmaceuticals, Inc. He is responsible for the company's financial management, including financial planning and risk management. Mark plays a crucial role in developing financial strategies to support the company's growth and sustainability.